You are a healthcare doctor having 20 years of experience . İ am a final year mbbs . İ want to become a cardiac surgeon . Make a list of all the clinically important drugs that İ am gonna memorize in my final year and also if İ want to become a cardiac surgeon
Reading File
Finding Sources
Searching the Web
clinically important drugs final year MBBS pharmacology cardiac surgery essential drug list
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have enough from the library and my clinical knowledge to give you a comprehensive, well-structured answer. Let me compile this.
Clinically Important Drugs: Final Year MBBS + Cardiac Surgery Track
As someone with 20 years at the bedside and in the OR, here's my honest advice — this is not just a list to memorize, it's a framework for how you'll think about patients your entire career. I've organized this into two tiers: what every final-year MBBS must know and what you need specifically for cardiac surgery.
TIER 1: Final Year MBBS — Core Pharmacology (Non-Negotiable)
1. 🫀 Cardiovascular Drugs
Antihypertensives
| Class | Key Drugs | High-Yield Points |
|---|---|---|
| ACE Inhibitors | Enalapril, Ramipril, Lisinopril | First-line in DM nephropathy, HF; cause dry cough; contraindicated in pregnancy |
| ARBs | Losartan, Valsartan, Telmisartan | ACE inhibitor intolerance; same renal protection |
| Beta-blockers | Metoprolol, Atenolol, Carvedilol | Cardioselective (β1) vs non-selective; Carvedilol in HF; contraindicated in asthma |
| CCBs | Amlodipine (dihydropyridine), Verapamil, Diltiazem | Amlodipine = vasodilator; Verapamil/Diltiazem = rate control (avoid in HF) |
| Diuretics | Furosemide (loop), HCTZ (thiazide), Spironolactone | Furosemide in acute pulmonary edema; Spiro in resistant HTN/HF |
| Centrally acting | Methyldopa, Clonidine | Methyldopa = drug of choice in pregnancy HTN |
Anti-anginals
| Drug | Mechanism | Key Use |
|---|---|---|
| GTN (sublingual nitrate) | NO donor → venodilation → ↓preload | Acute angina attack |
| Isosorbide mononitrate | Sustained nitrate | Prophylaxis of angina |
| Ranolazine | Late Na⁺ channel blocker | Refractory angina |
| Ivabradine | HCN channel blocker → ↓HR | Stable angina, HFrEF with sinus rhythm |
Antiarrhythmics (Vaughan-Williams Classification)
| Class | Drug | Use |
|---|---|---|
| Ia | Quinidine, Procainamide | AF, VT (less used now) |
| Ib | Lignocaine (Lidocaine) | Acute VT (IV), local anaesthesia |
| Ic | Flecainide, Propafenone | AF in structurally normal heart |
| II | Metoprolol, Esmolol | Rate control AF; peri-op arrhythmias |
| III | Amiodarone, Sotalol | Most important — AF, VF, VT; amiodarone is the broadest-spectrum antiarrhythmic |
| IV | Verapamil, Diltiazem | SVT, AF rate control |
| Other | Adenosine | Drug of choice for acute SVT (IV bolus) |
| Other | Digoxin | AF rate control in HF; narrow therapeutic index |
| Other | Atropine | Symptomatic bradycardia |
Heart Failure Drugs
| Drug | Class | Role |
|---|---|---|
| Furosemide | Loop diuretic | Symptom relief (decongestion) |
| Carvedilol / Metoprolol succinate | Beta-blocker | Reduce mortality in HFrEF |
| Enalapril / Ramipril | ACE inhibitor | Reduce mortality; remodeling |
| Sacubitril/Valsartan (Entresto) | ARNI | Superior to ACEi in HFrEF |
| Spironolactone / Eplerenone | MRA | Reduce mortality in HFrEF |
| Empagliflozin / Dapagliflozin | SGLT2i | Newest pillar; reduce hospitalization |
| Ivabradine | HCN blocker | HR reduction in HFrEF if HR >70 on beta-blocker |
| Digoxin | Cardiac glycoside | AF with HF; symptom reduction only |
| Hydralazine + Nitrate | Vasodilators | Alternative if ACEi/ARB not tolerated |
Lipid-lowering Drugs
| Drug | Class | Key Points |
|---|---|---|
| Atorvastatin, Rosuvastatin | Statins (HMG-CoA reductase inhibitor) | First-line; reduce LDL; pleiotropic effects; myopathy risk |
| Ezetimibe | Cholesterol absorption inhibitor | Add-on to statins |
| Evolocumab, Alirocumab | PCSK9 inhibitors | Very high-risk cardiovascular; injectable |
| Fenofibrate | Fibrate | Hypertriglyceridemia |
| Niacin | Raises HDL; flushing (reduced by aspirin) |
2. 🩸 Anticoagulants & Antiplatelets
| Drug | Class | Key Use | Reversal Agent |
|---|---|---|---|
| Aspirin (75–325 mg) | COX inhibitor | ACS, post-PCI, secondary prevention | — |
| Clopidogrel | P2Y12 inhibitor | ACS, post-stent (DAPT) | — |
| Ticagrelor | P2Y12 inhibitor | ACS (preferred over clopidogrel in NSTE-ACS) | — |
| Prasugrel | P2Y12 inhibitor | PCI-treated ACS | — |
| Unfractionated Heparin (UFH) | AT-III potentiator | ACS, cardiac surgery (CPB), bridging | Protamine sulfate |
| LMWH (Enoxaparin) | Anti-Xa | DVT, PE, ACS | Protamine (partial) |
| Warfarin | Vitamin K antagonist | AF, mechanical valves, VTE | Vitamin K, FFP, PCC |
| Dabigatran | Direct thrombin inhibitor | AF stroke prevention, VTE | Idarucizumab |
| Rivaroxaban, Apixaban | Direct Xa inhibitors | AF, VTE | Andexanet alfa |
| Fondaparinux | Selective Xa inhibitor | HIT alternative, ACS | — |
| Bivalirudin | Direct thrombin inhibitor | PCI, HIT patients in cardiac surgery | — |
| Abciximab, Eptifibatide, Tirofiban | GPIIb/IIIa inhibitors | High-risk PCI | — |
3. 🫁 Respiratory Drugs (for MBBS exams)
- Salbutamol (β2 agonist) — acute bronchospasm
- Ipratropium (anticholinergic) — COPD
- Theophylline — narrow TI; aminophylline IV in status asthmaticus
- Montelukast — leukotriene antagonist, asthma prophylaxis
- Inhaled corticosteroids (Budesonide, Fluticasone) — asthma maintenance
4. 💊 Diabetes Drugs
- Metformin — first-line T2DM; contraindicated in renal failure/surgery
- Sulfonylureas (Glipizide, Gliclazide) — hypoglycemia risk
- SGLT2i (Empagliflozin) — cardioprotective, now standard in T2DM + CVD
- GLP-1 agonists (Liraglutide, Semaglutide) — weight loss + CV benefit
- DPP-4 inhibitors (Sitagliptin) — safe in renal disease
- Insulin — all types (Rapid, Regular, NPH, Glargine) — must know sliding scale
5. 🧠 CNS/Anaesthesia-relevant Drugs (critical for surgery)
- Morphine, Fentanyl, Pethidine — opioid analgesics; respiratory depression
- Midazolam — benzodiazepine; sedation/premedication
- Ketamine — dissociative anaesthetic; bronchodilator; preserves BP
- Propofol — induction agent; hypotension in cardiac patients
- Neostigmine — reversal of NMB; always give with Atropine
- Succinylcholine — depolarizing NMB; fastest onset; hyperkalemia risk
- Rocuronium — non-depolarizing NMB; reversed by Sugammadex
6. 🦠 Antibiotics (Surgery-relevant)
- Cefazolin — standard surgical prophylaxis for cardiac surgery
- Vancomycin — MRSA coverage; cardiac surgery prophylaxis in penicillin allergy
- Gentamicin — gram-negative; nephrotoxic + ototoxic
- Metronidazole — anaerobes, C. difficile
- Piperacillin-tazobactam — broad-spectrum; post-op infections
- Carbapenems (Meropenem) — last resort; NDM organisms
7. 💉 Inotropes & Vasopressors (Shock Management)
| Drug | Receptor | Effect | Use |
|---|---|---|---|
| Dopamine | D1, β1, α1 (dose-dependent) | BP + inotropy | Cardiogenic/septic shock |
| Dobutamine | β1 predominantly | ↑Contractility, ↓SVR | Cardiogenic shock, HF |
| Norepinephrine | α1 > β1 | Vasoconstriction | Septic/distributive shock |
| Epinephrine | α1, β1, β2 | ↑HR, ↑CO, bronchodilation | Anaphylaxis, cardiac arrest |
| Vasopressin | V1 | Peripheral vasoconstriction | Refractory septic shock |
| Milrinone | PDE-3 inhibitor | ↑Contractility + vasodilation | Cardiogenic shock, post-cardiac surgery |
TIER 2: 🏥 Specifically for Cardiac Surgery
These are drugs you'll encounter daily in the cardiac ICU, operating theatre, and post-op ward.
1. Cardiopulmonary Bypass (CPB) — Essential Drugs
| Drug | Role |
|---|---|
| Heparin (300–400 IU/kg) | Anticoagulation during bypass; target ACT >480 sec |
| Protamine sulfate | Reversal of heparin post-bypass (1 mg per 100 IU heparin) |
| Potassium-based cardioplegia | Arrest of the heart; St. Thomas solution, Del Nido solution |
| Calcium (CaCl₂) | Terminate cardioplegia; improve contractility on coming off bypass |
| Tranexamic acid | Antifibrinolytic; reduce perioperative bleeding |
| Aprotinin (limited use) | Antifibrinolytic; controversial due to renal side effects |
| Mannitol | Added to bypass circuit priming; renal protection + osmotic diuresis |
2. Cardiac ICU / Post-operative
| Drug | Indication |
|---|---|
| Amiodarone | Post-op AF (most common post-cardiac surgery arrhythmia); VT/VF |
| Metoprolol / Esmolol | Rate control; esmolol is ultra-short acting (IV) — ideal in ICU |
| Digoxin | AF with poor LV function |
| Dobutamine / Milrinone | Low cardiac output syndrome post-bypass |
| Norepinephrine | Vasoplegic syndrome post-CPB |
| Vasopressin | Refractory vasoplegia post-CPB |
| Levosimendan | Calcium sensitizer; useful in pre-op poor LV function preparation |
| Furosemide | Post-op diuresis; fluid overload from CPB |
| Insulin infusion | Tight glycemic control in post-cardiac surgery (target 140–180 mg/dL) |
| Magnesium sulfate | Post-op AF prevention; hypomagnesemia post-bypass |
| Potassium chloride | Hypokalemia (arrhythmogenic post-bypass) |
3. Post-operative Cardiac Surgery (Discharge Medications)
| Drug | Indication |
|---|---|
| Aspirin (100 mg) | Post-CABG, post-valve surgery with bioprosthesis |
| Warfarin (INR 2.5–3.5) | Mechanical valves; INR target varies by valve position |
| Rivaroxaban/Apixaban | NOT recommended for mechanical valves (use warfarin) |
| Clopidogrel (DAPT) | Off-pump CABG, for 1 year post-op |
| Statin (Atorvastatin 40–80 mg) | All post-CABG patients; plaque stabilization |
| Beta-blocker | Post-CABG; reduce mortality, prevent AF |
| ACE inhibitor/ARB | Post-CABG with reduced EF or DM |
| Colchicine | Post-pericardiotomy syndrome prevention |
4. Drugs Used in Cardiac Catheterization / Cath Lab
| Drug | Role |
|---|---|
| Adenosine | FFR measurement; SVT termination |
| Nitrates (GTN IV) | Coronary vasodilation during angiography |
| Heparin / Bivalirudin | Anticoagulation during PCI |
| Contrast agents | Iodinated (watch for contrast nephropathy — hold metformin) |
| Atropine | Vasovagal during procedure; bradycardia |
| Abciximab / Eptifibatide | High-risk PCI (complex lesions, thrombus) |
5. Drugs for Specific Cardiac Conditions You'll Operate On
| Condition | Key Drugs |
|---|---|
| Aortic dissection (Type A) | IV Esmolol → Nitroprusside (target SBP 100–120, HR <60 before surgery) |
| Infective endocarditis | IV Penicillin G + Gentamicin (Strep); Nafcillin/Oxacillin (MSSA); Vancomycin (MRSA/Enterococcus) |
| Pulmonary hypertension | Sildenafil, Bosentan, Prostacyclins (Epoprostenol IV); iNO in ICU |
| Cardiac tamponade | Avoid diuretics; fluids to maintain preload; proceed to pericardiocentesis/surgery |
| Post-transplant | Tacrolimus, Cyclosporine (calcineurin inhibitors); Mycophenolate; Prednisolone |
High-Yield Memory Tips (From 20 Years of Teaching)
- The four pillars of HFrEF mortality reduction: ACEi/ARNI + Beta-blocker + MRA + SGLT2i
- Amiodarone is the most important antiarrhythmic in cardiac surgery — know all its toxicities (thyroid, pulmonary, hepatic, corneal deposits)
- Heparin reversal = Protamine — know the dose ratio and watch for protamine reactions (anaphylaxis in fish allergy/prior vasectomy)
- Warfarin for mechanical valves, DOACs for AF — this distinction will come in exams and clinical life forever
- Tranexamic acid is now mandatory in every cardiac surgery center — know its mechanism (antifibrinolytic, not anticoagulant)
- Never stop beta-blockers abruptly in cardiac patients — rebound angina/MI
- Levosimendan is a high-yield drug for the cardiac surgery viva — calcium sensitizer, not a classical inotrope, doesn't increase O₂ demand
- Post-op AF (30–50% of cardiac surgery cases) — first-line treatment is amiodarone + anticoagulation if persists >48 hours
Recommended Books to Master These Drugs
| Book | What to Read |
|---|---|
| KD Tripathi Pharmacology | Chapter-by-chapter cardiovascular section — gold standard for MBBS |
| Braunwald's Heart Disease | Drug management of each cardiac condition |
| Fuster & Hurst's The Heart (in your library) | Anticoagulant/antiplatelet chapter |
| Barash Clinical Anesthesia (in your library) | Perioperative cardiac pharmacology |
| Miller's Anesthesia (in your library) | ICU pharmacology, vasoactive drugs |
| Sabiston Textbook of Surgery (in your library) | Perioperative cardiac risk, surgical pharmacology |
This framework covers roughly 150+ drugs organized by clinical context rather than random lists. The drugs in Tier 2 are what will differentiate you in your MCh/post-graduate cardiac surgery viva from candidates who only know textbook pharmacology. Learn the why behind each drug — mechanism → indication → dose → side effect → contraindication — and you'll be unstoppable.
Good luck. Cardiac surgery is one of the most demanding and rewarding fields in medicine — start building these foundations now.
This is a shared conversation. Sign in to Orris to start your own chat.